Mapping the analytical toolbox for next-generation adjuvant immunology: A bibliometric analysis of characterization techniques and emerging trends (2006-2025).

Publication date: Jan 01, 2027

This study presents a comprehensive bibliometric analysis of next-generation immunomodulatory adjuvants (NIAs) and advanced immune characterisation research from 2006 to 2025, aiming to delineate the global landscape, thematic structure, and emerging frontiers in adjuvant immunology. A total of 8637 unique publications retrieved from the Web of Science Core Collection and Scopus were analysed using bibliometric, network, and co-occurrence approaches. The results show a sharp surge in research output since 2020, driven by mRNA-lipid nanoparticle vaccine development, with the United States and China emerging as dual global research hubs. Publications are distributed across five disciplinary domains centred on general/vaccine immunology, and institutional collaboration forms three major clusters dominated by the U. S., China, and Europe-Oceania respectively. Co-citation and keyword analyses reveal lipid nanoparticle/cGAS-STING signalling and mRNA vaccine/COVID-19 as the core mechanistic and translational axes. Advanced techniques including single-cell RNA sequencing, proteomics, and flow cytometry serve as critical bridges connecting adjuvant engineering to immune mechanism dissection. To our knowledge, this study represents the first systematic, data-driven mapping of the analytical technique landscape in next-generation adjuvant research. We uncover a previously unrecognised design-characterisation-mechanism-translation pipeline, revealing how advanced characterisation tools serve as the critical bridge between biomaterial engineering and immune mechanism dissection. These findings not only chart the intellectual structure of this rapidly expanding field but also provide a strategic roadmap for analytical chemists aiming to develop next-generation methodologies for adjuvant characterisation and programmable immunomodulation.

Concepts Keywords
Adjuvants, Immunologic
Adjuvants, Immunologic
Advanced characterization techniques
Animals
Bibliometric analysis
Bibliometrics
cGAS-STING pathway
cGAS-STING Signaling Pathway
Humans
Immunomodulation
Lipid Nanoparticles
Liposomes
Liposomes
mRNA vaccine
mRNA Vaccines
mRNA Vaccines
Nanoparticles
Single-cell RNA sequencing
Vaccine adjuvants
Vaccine Development

Semantics

Type Source Name
disease MESH STING
disease MESH COVID-19
pathway REACTOME Translation

Original Article

(Visited 5 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *